SCHEMBL19804189

SCHEMBL19804189

C=C(C)C(=O)OCCc1cc(CO)ccc1-c1ccc(-c2ccccc2)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.36
PTGS1 P23219 4/20 0.35
PGR P06401 1/20 0.35
PDE4A P27815 1/20 0.35
SLC6A9 P48067 1/20 0.35
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
EGFR P00533 1/20 0.34
DHODH Q02127 3/20 0.34
RARB P10826 3/20 0.34
FFAR1 O14842 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
MEN1 O00255 2/20 0.33
PTGS2 P35354 2/20 0.33
KMT2A Q03164 2/20 0.33
FABP2 P12104 1/20 0.33
TSHR P16473 1/20 0.33
AKR1C4 P17516 1/20 0.33
ADRA2B P18089 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804616 0.93 S1PR1 (0.35) S1PR1PTGS1PGRPDE4ASLC6A9
SCHEMBL19796780 0.88 RARB (0.47) S1PR1RARBMEN1KMT2ATSHR
SCHEMBL19801688 0.87 EGFR (0.38) PTGS1SLC6A9EGFRFFAR1FFAR4
SCHEMBL19804617 0.87 EGFR (0.38) PTGS1SLC6A9EGFRFFAR1FFAR4
SCHEMBL19804606 0.87 SLC6A9 (0.40) PTGS1PGRPDE4ASLC6A9CYP4F2
SCHEMBL19804528 0.85 PTGS1 (0.38) S1PR1PTGS1PGRPDE4ASLC6A9
SCHEMBL19796365 0.85 CYP4F2 (0.37) CYP4F2CYP4A11FFAR1FFAR4TSHR
SCHEMBL19796326 0.84 CYP4F2 (0.36) CYP4F2CYP4A11RARBTSHRTHRB
SCHEMBL19804370 0.84 PTGS1 (0.39) S1PR1PTGS1PGRPDE4ASLC6A9
SCHEMBL19804609 0.84 RARB (0.39) S1PR1PTGS1PGRPDE4ARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 S1PR1 98/4885PTGS1 4342/4885PGR 2255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.